相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A Community Cluster of Oseltamivir-Resistant Cases of 2009 H1N1 Influenza
Le Quynh Mai et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
CS-8958, a Prodrug of the New Neuraminidase Inhibitor R-125489, Shows Long-Acting Anti-Influenza Virus Activity
Makoto Yamashita et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Synthesis and in vivo influenza virus-inhibitory effect of ester prodrug of 4-guanidino-7-O-methyl-Neu5Ac2en
Takeshi Honda et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2009)
Detection of an oseltamivir-resistant pandemic influenza A/H1N1 virus in Hong Kong
Tommy W. C. Leung et al.
JOURNAL OF CLINICAL VIROLOGY (2009)
Emergence and pandemic potential of swine-origin H1N1 influenza virus
Gabriele Neumann et al.
NATURE (2009)
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans Novel Swine-Origin Influenza A (H1N1) Virus Investigation Team
Fatimah S. Dawood et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Oseltamivir-Resistant Influenza Viruses A (H1N1), Norway, 2007-08
Siri H. Hauge et al.
EMERGING INFECTIOUS DISEASES (2009)
Oseltamivir-Ribavirin Combination Therapy for Highly Pathogenic H5N1 Influenza Virus Infection in Mice
Natalia A. Ilyushina et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2008)
The potential impact of neuraminidase inhibitor resistant influenza
Angie Lackenby et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2008)
A Randomized, Crossover Study to Evaluate the Pharmacokinetics of Amantadine and Oseltamivir Administered Alone and in Combination
Dennis Morrison et al.
PLOS ONE (2007)
Emergence of influenza B viruses with reduced sensitivity to neuraminidase inhibitors
Shuji Hatakeyama et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Comparative activities of oseltamivir and A-322278 in immunocompetent and immunocompromised murine models of influenza virus infection
MG Ison et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Oseltamivir (Tamiflu®) and its potential for use in the event of an influenza pandemic
P Ward et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
Resistant influenza A viruses in children treated with oseltarnivir: descriptive study
M Kiso et al.
LANCET (2004)
Neuraminidase inhibitor-rimantadine combinations exert additive and synergistic anti-influenza virus effects in MDCK cells
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Position statement: global neuraminidase inhibitor susceptibility network
M Zambon et al.
ANTIVIRAL RESEARCH (2001)
Influenza virus neuraminidase inhibitors
LV Gubareva et al.
LANCET (2000)
分享论文
